Atlas Trials

AML With Mutated NPM1

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch AML With Mutated NPM1

RecordFirmDate
Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation (NCT07566585)BlueSphere Bio, Inc2026-04-21
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT06001788)Kura Oncology, Inc.2024-02-22
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML (NCT05735184)Kura Oncology, Inc.2023-07-18

Track AML With Mutated NPM1 automatically

Every clearance here is in the API, with alerts when new ones post.